Coherus Oncology, Inc. Financial Ratios — CHRS Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-145	-74.26	-111.74	-65.16	-139.65	-159.75	35.34	21.15	-37.75	-50.29	-42.85	5.29	47.54
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-13.46	-29.06	- -	- -	- -	-4.68	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	58.24	30.71	- -	- -	- -	-52.51	- -
Gross Margin (%)	100	100	100	100	100	100	- -	95.2	92.08	82.36	66.79	38.19	66.93	67.24
EBITDA Margin (%)	-2,016.69	-1,293.68	-205.77	-723.01	-59.41	-14,700.39	- -	31.18	33.46	-79.74	-119.97	-77.52	-736.58	-420.21
Operating Margin (%)	-2,028.33	-1,308.36	-207.94	-729.23	-60.98	-14,918.77	- -	30.27	32.85	-80.8	-121.72	-78.99	-756.58	-429.51
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	-1,781.49	87.67	40.54	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,738.7	-1,949.65	-280.26	-745.44	-67.22	-15,314.01	- -	26.06	28.52	-87.92	-138.24	-92.62	-816.23	-434.23
Profit Margin (%)	-1,738.7	-1,949.65	-280.12	-743.18	-66.98	-15,306.56	- -	25.23	27.79	-87.92	-138.24	-92.48	108.03	398.43
Net Income to Common Margin (%)	-1,738.7	-1,949.65	-280.12	-743.18	-66.98	-15,306.56	- -	25.23	27.79	-87.92	-138.24	-92.48	108.03	398.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	3.17	2.55	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	4	- -	- -	101	102	103	189	417	419	480	481	270	40
ST Debt	2	4	- -	- -	1	- -	- -	- -	3	3	4	2	2	2
LT Debt	- -	- -	- -	- -	100	102	103	189	414	416	476	479	268	39
Total Debt/EBITDA	-0.05	-0.12	- -	- -	-0.9	-0.45	-0.51	1.7	2.62	-1.61	-1.9	-2.41	-1.39	-0.23
Net Debt/EBITDA	0.33	0.99	2.35	0.73	0.21	0.11	-0.15	0.01	-0.86	0.03	-1.61	-1.86	-0.71	0.29
Total Debt/EBIT	-0.05	-0.12	- -	- -	-0.87	-0.44	-0.5	1.75	2.67	-1.59	-1.87	-2.37	-1.35	-0.22
Net Debt/EBIT	0.33	0.98	2.33	0.72	0.21	0.11	-0.15	0.01	-0.88	0.03	-1.59	-1.82	-0.7	0.29
EBITDA to Interest Expense	-25.3	-6.72	-16.41	-6,581.76	-14.15	-23.95	-20.77	6.31	7.52	-11.34	-7.8	-4.92	-18.11	-19.69
EBITDA-CapEx/Interest Expense	-26.47	-6.79	-17.14	-6,768.55	-14.97	-24.43	-20.86	5.58	7.18	-11.4	-7.86	-4.93	-18.11	-19.69
EBIT to Interest Expense	-25.44	-6.8	-16.59	-6,638.39	-14.53	-24.3	-21.11	6.12	7.39	-11.49	-7.91	-5.01	-18.6	-20.12
Interest Expense	2	5	4	- -	8	10	10	18	21	23	32	41	11	9
Common Equity/Total Assets	-173.2	-209.9	-99.73	-193.04	-301.04	-476.9	-990.1	-218.86	-90.63	-154.54	-279.01	-250.87	-345.79	-535.32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	518.01	332.76	- -	179.29	147.33	425.2	- -	- -	- -	63.11
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-22.92	-15.05	-11.69	-26.71	-119.77	-65.87	-55.29	-43.57	-20.94	-2.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	56.17	62.49	103.64	46.13	49.19	61.17	99.01	76.03	59.8	14.91
Total Debt/Equity (%)	18.91	-9.92	- -	- -	522.54	333.52	-267.14	179.29	148.45	428.77	-349.61	-248.59	-204.49	66.11
Total Debt/Capital (%)	16.59	-10.33	- -	- -	-23.12	-15.09	-11.69	-26.71	-120.67	-66.42	-55.79	-43.77	-21.07	-3
Total Debt/Total Assets (%)	6.55	8.86	- -	- -	56.66	62.63	103.64	46.13	49.56	61.68	99.91	76.37	60.17	15.61
Net Debt to Equity	-139.36	83.41	-225.28	2,283.53	-123.04	-82.1	-79.65	0.68	-48.81	-9.12	-296.55	-191.54	-105.27	-84.94
Net Debt/Capital (%)	314.66	44.05	44.61	27.81	4.24	3.13	-3.22	-0.08	15.46	0.85	-44.07	-30.83	-9.87	3.62
EBITDA	-38	-36	-64	-217	-113	-229	-201	111	159	-260	-253	-199	-194	-177
EBITDA-CapEx	-40	-36	-67	-223	-119	-233	-202	98	152	-262	-255	-200	-194	-177
Operating Income (Loss)	-39	-36	-65	-219	-116	-232	-204	108	156	-264	-257	-203	-200	-181

Liquidity (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.29	0.74	2.9	1.49	2.22	4.47	2.18	1.55	3.72	2.52	1.38	0.35	0.45	1.21
Current Ratio	2.2	0.85	3.46	1.86	2.86	5.12	2.54	2.98	5.27	3.64	2.75	1.43	1.21	1.46
Quick Ratio	1.31	0.74	2.99	1.51	2.25	4.47	2.18	2.78	4.79	3.27	2.17	1.14	0.88	1.34
CFO/Avg Current Liab	- -	0.47	-0.45	-1.37	-3.11	-4.73	-5.17	0.38	1.18	-0.24	-1.59	-0.74	-0.07	-0.65
Common Equity/Total Assets	-173.2	-209.9	-99.73	-193.04	-301.04	-476.9	-990.1	-218.86	-90.63	-154.54	-279.01	-250.87	-345.79	-535.32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	518.01	332.76	- -	179.29	147.33	425.2	- -	- -	- -	63.11
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-22.92	-15.05	-11.69	-26.71	-119.77	-65.87	-55.29	-43.57	-20.94	-2.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	56.17	62.49	103.64	46.13	49.19	61.17	99.01	76.03	59.8	14.91
Total Debt/Equity (%)	18.91	-9.92	- -	- -	522.54	333.52	-267.14	179.29	148.45	428.77	-349.61	-248.59	-204.49	66.11
Total Debt/Capital (%)	16.59	-10.33	- -	- -	-23.12	-15.09	-11.69	-26.71	-120.67	-66.42	-55.79	-43.77	-21.07	-3
Total Debt/Total Assets (%)	6.55	8.86	- -	- -	56.66	62.63	103.64	46.13	49.56	61.68	99.91	76.37	60.17	15.61
CFO/Total Liabilities	-105.25	17.17	-19.86	-49.24	-158.7	-151.64	-115.36	9.34	27.49	-6.44	-39	-21.25	-3.52	-70.19
CFO/CapEx	-10.24	41.35	-8.4	-17.52	-38.76	-43.8	-201.86	2.2	21.32	-29.04	-118.26	-611.48	- -	- -
Altman's Z-Score	-6.53	-5.59	-0.92	-3.21	-0.23	-8.63	-18.21	1.82	2.13	-0.96	-4.09	-4.17	-6.76	-10.88

Working Capital (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	12.62	23.08	15.11	111.21	1.67	- -	5.02	3.18	2.33	1.81	1.39	0.14	0.65
Days Sales Outstanding	- -	28.92	15.81	24.16	3.28	218.04	- -	72.78	114.69	156.52	201.48	262.84	2,571.6	558.85
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	2.98	1.39	1.41	1.83	3.14	0.26	3.74
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	122.53	261.83	259.45	199.04	116.39	1,397.18	97.49
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.11	1.22	3.5	3.25	5.15	7.82	-1.56	0.67
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	3,411.07	298.64	104.26	112.22	70.93	46.67	-233.95	547.99
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-103.33	272.26	303.76	329.58	332.56	4,202.73	108.35
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-49.75	-147.13	-102.93	2.44	146.45	1,174.42	461.37
Inventories	- -	- -	- -	- -	- -	- -	2	10	44	38	39	63	4	3
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	2	10	44	38	39	63	4	3

Enterprise Value (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	134	852	1,180	468	589	1,255	1,241	1,204	615	314	158	166
- Cash & Cash Equivalents	15	40	150	158	125	127	72	178	541	417	64	103	126	89
+ Preferred Equity and Hybrid Capital	55	55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	-1	-1	-1	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	4	- -	- -	101	102	103	189	417	419	480	481	270	40
Enterprise Value	42	19	-17	693	1,155	441	619	1,266	1,117	1,206	904	677	302	35
Total Capital	10	-41	-187	-411	-437	-675	-882	-706	-346	-631	-861	-1,099	-1,281	-1,343
Total Debt/Capital (%)	16.59	-10.33	- -	- -	-23.12	-15.09	-11.69	-26.71	-120.67	-66.42	-55.79	-43.77	-21.07	-3
Total Debt / EV	0.04	0.22	- -	- -	0.09	0.23	0.17	0.15	0.37	0.35	0.53	0.71	0.89	1.17
EV/Sales	22.06	7.03	- -	23.08	6.07	283.56	- -	3.55	2.35	3.69	4.28	2.63	11.44	0.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	11.4	7.02	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	11.74	7.15	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	0.93	- -	- -	- -	- -	- -	27.88	6.39	- -	- -	- -	44.95	- -
EV/Free Cash Flow to Firm	- -	0.92	- -	- -	- -	- -	- -	21.71	6.14	- -	- -	- -	44.95	- -
Diluted Market Cap	- -	- -	134	852	1,180	468	589	1,318	1,451	1,204	615	314	158	166
Diluted Enterprise Value	42	19	-17	693	1,155	441	619	1,329	1,327	1,206	1,032	692	302	118
EV per Share	2.32	1.07	- -	18.68	27.55	8.3	9.52	18.16	15.64	15.98	11.64	7.19	2.64	0.29
TTM Sales	2	3	31	30	190	2	- -	356	476	327	211	257	26	42
TTM EBITDA	-38	-36	-64	-217	-113	-229	-201	111	159	-260	-253	-199	-194	-177
TTM Operating Income	-39	-36	-65	-219	-116	-232	-204	108	156	-264	-257	-203	-200	-181
TTM Cash Flow to Firm	-17	21	-20	-108	-245	-191	-150	45	175	-14	-209	-134	-10	-130
TTM Free Cash Flow to Firm	-15	21	-17	-102	-238	-186	-149	58	182	-13	-207	-134	-10	-130

Multiples (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.34	-8.37	-4.8	-2.39	-3.71	31.94	8.99	-33.32	-2.57	-1.8	-7.75	-1.2
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	11.74	7.15	- -	- -	- -	- -	- -
Enterprise Value	42	19	-17	693	1,155	441	619	1,266	1,117	1,206	904	677	302	35
Low Price	- -	- -	12.27	15.5	12.04	8.05	8.39	8.32	10.86	12.21	5.58	1.43	0.66	0.71
EV/Sales	22.06	7.03	- -	23.08	6.07	283.56	- -	3.55	2.35	3.69	4.28	2.63	11.44	0.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	11.4	7.02	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	13.97	9.39	- -	- -	- -	5.55	0.99
Price/Earnings Average	- -	- -	-1.33	-4.46	-7.46	-3.77	-4.24	13.44	9.69	-4.16	-2.61	-2.07	6.96	0.8
Price/Earnings High	- -	- -	-1.63	-6.33	-10.53	-6.6	-6.42	18.55	12.44	-5.84	-4.39	-4.35	14.87	1.32
Price/Earnings Low	- -	- -	-1.15	-2.58	-3.96	-1.8	-2.61	6.45	5.87	-3.21	-1.48	-0.57	2.65	0.49
Price/Book Value	- -	- -	-0.72	-2.08	-2.2	-0.6	-0.6	-1.4	-1.63	-1.15	-0.46	-0.2	-0.1	-0.12
Price/Book Value Average	- -	- -	-0.62	-2.43	-1.77	-1.16	-0.9	-1.35	-1.68	-1.14	-0.57	-0.31	-0.13	-0.1
Price/Book Value High	- -	- -	-0.76	-3.45	-2.49	-2.03	-1.36	-1.86	-2.16	-1.6	-0.95	-0.66	-0.27	-0.16
Price/Book Value Low	- -	- -	-0.54	-1.4	-0.94	-0.55	-0.55	-0.65	-1.02	-0.88	-0.32	-0.09	-0.05	-0.06
Price/Tangible Book Value	- -	- -	2.11	-81.24	74.72	17.34	-13.96	12.34	4.47	12.79	-4.29	-1.18	-0.85	11.26
Price/Tangible Book Value Average	- -	- -	1.83	-94.96	60.14	33.31	-21.08	11.88	4.62	12.67	-5.31	-1.86	-1.07	9.1
Price/Tangible Book Value High	- -	- -	2.24	-134.8	84.88	58.29	-31.88	16.39	5.93	17.8	-8.92	-3.9	-2.28	14.98
Price/Tangible Book Value Low	- -	- -	1.59	-54.84	31.96	15.86	-12.94	5.7	2.8	9.78	-3.02	-0.51	-0.41	5.63
Price/Sales	- -	- -	4.3	28.37	6.21	300.5	- -	3.52	2.61	3.69	2.91	1.22	5.99	3.94
Price/Sales Average	- -	- -	3.71	33.17	5	577.48	- -	3.39	2.69	3.65	3.61	1.91	7.52	3.19
Price/Sales High	- -	- -	4.56	47.08	7.05	1,010.43	- -	4.68	3.46	5.13	6.06	4.02	16.06	5.25
Price/Sales Low	- -	- -	3.23	19.15	2.65	274.89	- -	1.63	1.63	2.82	2.05	0.52	2.87	1.97
Price/Cash Flow	- -	- -	-5.58	-7.89	-4.67	-2.33	-3.7	44.25	8.05	-32.17	-2.55	-1.79	-7.73	-1.2
Price/Cash Flow Average	- -	- -	-4.83	-9.23	-3.76	-4.49	-5.58	42.59	8.32	-31.88	-3.16	-2.81	-9.71	-0.97
Price/Cash Flow High	- -	- -	-5.92	-13.1	-5.31	-7.85	-8.44	58.76	10.67	-44.78	-5.31	-5.92	-20.74	-1.6
Price/Cash Flow Low	- -	- -	-4.2	-5.33	-2	-2.14	-3.43	20.45	5.03	-24.61	-1.8	-0.77	-3.7	-0.6
Price/Free Cash Flow Average	- -	- -	-5.48	-9.78	-3.86	-4.59	-5.61	30.74	9.29	-33.01	-3.18	-2.82	-9.73	-0.97
Price/Free Cash Flow High	- -	- -	-6.72	-13.89	-5.45	-8.03	-8.48	42.42	11.92	-46.38	-5.35	-5.93	-20.79	-1.6
Price/Free Cash Flow Low	- -	- -	-4.77	-5.65	-2.05	-2.19	-3.44	14.76	5.62	-25.49	-1.81	-0.77	-3.71	-0.6
EV/Sales Average	22.06	7.03	- -	27.88	4.86	560.54	- -	3.42	2.43	3.66	5.58	3.38	12.97	2.04
EV/Sales High	22.06	7.03	- -	41.79	6.92	993.49	- -	4.71	3.2	5.14	8.04	5.49	21.52	4.1
EV/Sales Low	22.06	7.03	- -	13.86	2.52	257.95	- -	1.66	1.37	2.83	4.03	1.99	8.32	0.82
EV/EBITDA Average	-1.09	-0.54	0.55	-3.86	-8.19	-3.81	-4.57	10.97	7.27	-4.59	-4.65	-4.36	-1.76	-0.49
EV/EBITDA High	-1.09	-0.54	0.14	-5.78	-11.65	-6.76	-6.83	15.1	9.55	-6.44	-6.7	-7.09	-2.92	-0.98
EV/EBITDA Low	-1.09	-0.54	0.78	-1.92	-4.25	-1.75	-2.86	5.32	4.09	-3.54	-3.36	-2.57	-1.13	-0.2
EV/EBIT Average	-1.09	-0.54	0.54	-3.82	-7.98	-3.76	-4.5	11.31	7.41	-4.53	-4.58	-4.28	-1.71	-0.47
EV/EBIT High	-1.09	-0.54	0.13	-5.73	-11.35	-6.66	-6.72	15.56	9.73	-6.36	-6.6	-6.95	-2.84	-0.95
EV/EBIT Low	-1.09	-0.54	0.77	-1.9	-4.14	-1.73	-2.82	5.48	4.17	-3.5	-3.31	-2.52	-1.1	-0.19
Last Price	- -	- -	16.32	22.96	28.15	8.8	9.05	18	17.38	15.96	7.92	3.33	1.38	1.42
High Price	- -	- -	17.31	38.1	31.98	29.59	20.66	23.91	23.03	22.22	16.48	10.99	3.7	1.89
Enterprise Value Average	42	19	-35	837	925	872	919	1,218	1,158	1,195	1,178	870	342	86
Enterprise Value High	42	19	-9	1,255	1,315	1,546	1,374	1,677	1,521	1,678	1,696	1,413	568	173
Enterprise Value Low	42	19	-50	416	480	401	576	591	652	923	850	513	220	35

Shares Outstanding	32	32	33	39	46	60	68	70	73	77	79	112	116	121
Diluted Weighted Avg Shares	18	18	8	37	42	53	65	73	83	75	78	94	115	117
Basic Weighted Avg Shares	18	18	8	37	42	53	65	70	71	75	78	94	115	117
Revenue per Share	0.11	0.15	3.8	0.81	4.54	0.03	- -	5.11	6.66	4.33	2.72	2.73	0.23	0.36
EBITDA per Share	-2.12	-1.97	-7.82	-5.85	-2.69	-4.3	-3.09	1.59	2.23	-3.45	-3.26	-2.12	-1.7	-1.51
Operating Income per Share	-2.13	-1.99	-7.9	-5.9	-2.77	-4.37	-3.14	1.55	2.19	-3.5	-3.31	-2.16	-1.74	-1.55
Basic EPS, GAAP	-1.83	-2.97	-10.64	-6.01	-3.04	-4.48	-3.22	1.29	1.85	-3.81	-3.76	-2.53	0.25	1.43
Basic EPS from Cont Ops	-1.83	-2.97	-10.65	-6.03	-3.05	-4.48	-3.22	1.29	1.85	-3.81	-3.76	-2.53	-1.88	-1.56
Diluted EPS, GAAP	-1.83	-2.97	-10.64	-6.01	-3.04	-4.48	-3.22	1.23	1.58	-3.81	-3.76	-2.53	0.25	1.43
Diluted EPS from Cont Ops	-1.83	-2.97	-10.65	-6.03	-3.05	-4.48	-3.22	1.23	1.58	-3.81	-3.76	-2.53	-1.88	-1.56
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.01	0.85	-2.92	-2.91	-6.03	-3.77	-2.45	0.41	2.16	-0.5	-3.11	-1.86	-0.18	-1.18
Free Cash Flow per Basic Share	-1.11	0.83	-3.27	-3.08	-6.18	-3.86	-2.46	0.22	2.06	-0.51	-3.13	-1.86	-0.18	-1.18
Cash & Equivalents per Share	0.8	2.19	18.37	4.26	2.98	2.39	1.11	2.55	7.58	5.53	2.47	1.25	1.1	1.47
Book Value per Share	-2.54	-5.51	-22.81	-11.04	-12.82	-14.6	-15.14	-12.84	-10.68	-13.91	-17.28	-16.77	-13.54	-11.81
Tangible Book Value per Share	-2.52	-5.37	7.72	-0.28	0.38	0.51	-0.65	1.46	3.88	1.25	-1.85	-2.82	-1.62	0.13

Coherus Oncology, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)